The market already has plenty to worry about between looming interest rate hikes, decades-high inflation, and geopolitical tensions. But it now has another concern: Mounting COVID cases and restrictions in China could have a profound impact on the global economic outlook in the near future.
As a result, the Nasdaq Composite has tumbled 23% below its 52-week high. Due in large part to that market volatility, small-cap medical device stock AngioDynamics (NASDAQ: ANGO) is 32.7% off of its 52-week high.
Here are three reasons why the Nasdaq's bear market appears to have made AngioDynamics a bargain buy for growth investors.
For further details see:
3 Reasons to Consider Buying This Overlooked Medical Device Stock